BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26878899)

  • 21. Outlier mining in high throughput screening experiments.
    Engels MF; Wouters L; Verbeeck R; Vanhoof G
    J Biomol Screen; 2002 Aug; 7(4):341-51. PubMed ID: 12230888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assay development and high-throughput screening of small molecular c-Abl kinase activators.
    Cottom J; Hofmann G; Siegfried B; Yang J; Zhang H; Yi T; Ho TF; Quinn C; Wang DY; Johanson K; Ames RS; Li H
    J Biomol Screen; 2011 Jan; 16(1):53-64. PubMed ID: 20938045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput screening of libraries of compounds to identify CFTR modulators.
    Pedemonte N; Zegarra-Moran O; Galietta LJ
    Methods Mol Biol; 2011; 741():13-21. PubMed ID: 21594775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QSAR classification model for antibacterial compounds and its use in virtual screening.
    Singh N; Chaudhury S; Liu R; AbdulHameed MD; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Oct; 52(10):2559-69. PubMed ID: 23013546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening.
    Mansour NR; Bickle QD
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e795. PubMed ID: 20706580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel Pim-1 kinase inhibitors by a hierarchical multistage virtual screening approach based on SVM model, pharmacophore, and molecular docking.
    Ren JX; Li LL; Zheng RL; Xie HZ; Cao ZX; Feng S; Pan YL; Chen X; Wei YQ; Yang SY
    J Chem Inf Model; 2011 Jun; 51(6):1364-75. PubMed ID: 21618971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New directions in library design and analysis.
    Gillet VJ
    Curr Opin Chem Biol; 2008 Jun; 12(3):372-8. PubMed ID: 18331851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Process validation and screen reproducibility in high-throughput screening.
    Coma I; Clark L; Diez E; Harper G; Herranz J; Hofmann G; Lennon M; Richmond N; Valmaseda M; Macarron R
    J Biomol Screen; 2009 Jan; 14(1):66-76. PubMed ID: 19171922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery.
    Wu B; Zhang Z; Noberini R; Barile E; Giulianotti M; Pinilla C; Houghten RA; Pasquale EB; Pellecchia M
    Chem Biol; 2013 Jan; 20(1):19-33. PubMed ID: 23352136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput fluorescence polarization assay for chemical library screening against anti-apoptotic Bcl-2 family member Bfl-1.
    Zhai D; Godoi P; Sergienko E; Dahl R; Chan X; Brown B; Rascon J; Hurder A; Su Y; Chung TD; Jin C; Diaz P; Reed JC
    J Biomol Screen; 2012 Mar; 17(3):350-60. PubMed ID: 22156224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of peptide substrate and small molecule inhibitors of testis-specific serine/threonine kinase1 (TSSK1) by the developed assays.
    Zhang L; Yan Y; Liu Z; Abliz Z; Liu G
    J Med Chem; 2009 Jul; 52(14):4419-28. PubMed ID: 19530700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a high-throughput screening method for LIM kinase 1 using a luciferase-based assay of ATP consumption.
    Mezna M; Wong AC; Ainger M; Scott RW; Hammonds T; Olson MF
    J Biomol Screen; 2012 Apr; 17(4):460-8. PubMed ID: 22156225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-content analysis of kinase activity in cells.
    Gasparri F; Sola F; Bandiera T; Moll J; Galvani A
    Comb Chem High Throughput Screen; 2008 Aug; 11(7):523-36. PubMed ID: 18694389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational methods for the selection of diverse screening compounds.
    Huggins DJ; Venkitaraman AR; Spring DR
    ACS Chem Biol; 2011 Mar; 6(3):208-17. PubMed ID: 21261294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stratified high-throughput screening sets enable flexible screening strategies from a single plated collection.
    Nissink JW; Schmitt S; Blackburn S; Peters S
    J Biomol Screen; 2014 Mar; 19(3):369-78. PubMed ID: 23918919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical and biological properties of frequent screening hits.
    Che J; King FJ; Zhou B; Zhou Y
    J Chem Inf Model; 2012 Apr; 52(4):913-26. PubMed ID: 22435989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient identification of novel leads by dynamic focused screening: PDK1 case stud.
    Sun D; Jung J; Rush TS; Xu Z; Weber MJ; Bobkova E; Northrup A; Kariv I
    Comb Chem High Throughput Screen; 2010 Jan; 13(1):16-26. PubMed ID: 20214573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of nearest-neighbor and cluster analyses in pharmaceutical lead discovery.
    Stanton DT; Morris TW; Roychoudhury S; Parker CN
    J Chem Inf Comput Sci; 1999; 39(1):21-7. PubMed ID: 9987851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.